Grants per year
Personal profile
Education/Academic qualification
Biochemistry, PhD, Brandeis University
Chemistry, BS, City University of New York
Fingerprint Dive into the research topics where Jack Henkin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 2 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants
- 7 Finished
Novel Antiangiogenic Peptides for Treatment of Exudative AMD
University of Wisconsin-Madison, Kennedy Institute - National Eye Clinic
3/1/17 → 2/28/18
Project: Research project
Mazar subproject for Novel Antiangiogenic Peptides for Treatment of Exudative AMD
Henkin, J. & Mazar, A. P.
University of Wisconsin-Madison, Kennedy Institute - National Eye Clinic
3/1/16 → 2/28/17
Project: Research project
Subproject for Novel Antiangiogenic Peptides for Treatment of Exudative AMD SP0032001
Henkin, J. & Mazar, A. P.
University of Wisconsin-Madison, Kennedy Institute - National Eye Clinic
3/1/15 → 2/29/16
Project: Research project
Subproject for Novel Antiangiogenic Peptides for Treatment of Exudative AMD
Henkin, J. & Mazar, A. P.
University of Wisconsin-Madison, Kennedy Institute - National Eye Clinic
3/1/14 → 2/28/15
Project: Research project
Novel Antiangiogenic Peptides for Treatment of Exudative AMD
Henkin, J., Mazar, A. P., Volpert, O. & Zhang, H. F.
University of Wisconsin-Madison, Kennedy Institute - National Eye Clinic
3/1/14 → 2/28/15
Project: Research project
Research Output
Inhibition of retinal neovascularization by a PEDF-derived nonapeptide in newborn mice subjected to oxygen-induced ischemic retinopathy
Sheibani, N., Zaitoun, I. S., Wang, S., Darjatmoko, S. R., Suscha, A., Song, Y. S., Sorenson, C. M., Shifrin, V., Albert, D. M., Melgar-Asensio, I., Kandela, I. & Henkin, J., Jun 2020, In : Experimental eye research. 195, 108030.Research output: Contribution to journal › Article
Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization
Sheibani, N., Wang, S., Darjatmoko, S. R., Fisk, D. L., Shahi, P. K., Pattnaik, B. R., Sorenson, C. M., Bhowmick, R., Volpert, O., Albert, D. M., Melgar-Asensio, I. & Henkin, J., Nov 2019, In : Experimental eye research. 188, 107798.Research output: Contribution to journal › Article
4
Scopus
citations
Extended intravitreal rabbit eye residence of nanoparticles conjugated with cationic arginine peptides for intraocular drug delivery: In vivo imaging
Melgar-Asensio, I., Kandela, I., Aird, F., Darjatmoko, S. R., de los Rios, C., Sorenson, C. M., Albert, D. M., Sheibani, N. & Henkin, J., Aug 2018, In : Investigative Ophthalmology and Visual Science. 59, 10, p. 4071-4081 11 p.Research output: Contribution to journal › Article
3
Scopus
citations
Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma
Tiram, G., Ferber, S., Ofek, P., Eldar-Boock, A., Ben-Shushan, D., Yeini, E., Krivitsky, A., Blatt, R., Almog, N., Henkin, J., Amsalem, O., Yavin, E., Cohen, G., Lazarovici, P., Lee, J. S., Ruppin, E., Milyavsky, M., Grossman, R., Ram, Z., Calderón, M. & 2 others, , Nov 2018, In : FASEB Journal. 32, 11, p. 5835-5850 16 p.Research output: Contribution to journal › Article
3
Scopus
citations
Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome
Ferber, S., Tiram, G., Sousa-Herves, A., Eldar-Boock, A., Krivitsky, A., Scomparin, A., Yeini, E., Ofek, P., Ben-Shushan, D., Vossen, L. I., Licha, K., Grossman, R., Ram, Z., Henkin, J., Ruppin, E., Auslander, N., Haag, R., Calderón, M. & Satchi-Fainaro, R., Oct 4 2017, In : eLife. 6, e25281.Research output: Contribution to journal › Article
8
Scopus
citations